Dr. Elisa Port, MD

Medical School - Icahn School of Medicine at Mount Sinai, Doctor of Medicine

Cedars-Sinai Medical Center, Residency in General Surgery

Long Island Jewish Medical Center, Residency in General Surgery

Memorial Sloan Kettering Cancer Center (Fellowship)

Dartmouth College (Bachelor's)

The Mount Sinai Hospital

American Board of Surgery

American Society of Breast Disease

Society of Surgical Oncology

American Society of Breast Surgeons

Castle Connolly Top Doctor

Dr. Port was awarded Honors in Surgery by Mount Sinai School of Medicine in 1992

Dr. Port was awarded Third Honor Group by Dartmouth College in 1986

Port ER, Patil S, Stempel M, Morrow M, Cody HS. The Number of Nodes Removed in Sentinel Node-Negative Breast Cancer Patients is Significantly Related to Patient Age and Tumor Size: A New Source of Bias in Morbidity Assessment? . Cancer 2010 FEB;.

Chung A, Schoder H, Sampson M, Morrow M, Port ER. Incidental Breast Lesions Identified by 18F-Fluorodeoxyglucose-Positron Emission Tomography. . Ann Surg Oncol 2010 FEB;.

Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Flowers C, Troyan S, Garber J, Olopade O, Hylton N, Port ER, Campbell MC, Esserman LJ. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. . Breast Can Res Treat 2010; 119(1): 137-144.

Female

#1669457248